Suzhou Evermed Biomedical Co., Ltd (aka “Evermed”) was established in March 2012. We are a US/China joint venture with headquarters located at the National New Hi-Tech Industrial Development Zone in Suzhou, China.
Evermed excels at research, development, and manufacture of in Vitro Diagnostics (IVD) reagents for automatic chemistry analyzers. Our branded reagents have gone through the rigorous China FDA approval process, and we continue to work on expanding our catalog of approved products. Our professional sales and customer support team has built up a large distribution network to supply our IVD reagents to hospitals and reference laboratories throughout China. At the same time, we provide bulk OEM reagents to IVD companies and independent laboratories internationally.
Directed by U.S. experts with more than 20 years of experience in Homogeneous Enzyme Immunoassay (HEIA) development, Evermed’s research team has successfully developed many small molecule HEIAs, as well as, liquid reagent assays using other technologies. Our current lines of immunoassays include: Homogeneous Enzyme Immunoassays (HEIA), Turbidimetric Immunoassay (TIA), Microparticle Enhanced Immunoassay (MEIA), and Enzymatic Assay.
All of our assays are liquid reagents designed for chemistry analyzers.
Evermed Product Portfolio Covers following.
Evermed’s core values are Innovation, Quality and Service. We will continue to improve and develop unique HEIA assays meet stable performance.
All our products are evaluated thoroughly in our development process before they are released to manufacturing. Our manufacturing process is well documented and all products must pass rigid Quality Control testing to ensure consistent lot to lot performance for our customers.
We enjoy a close partnership with SJK Global LLC in US to manufacture, distribute, and service our products in US, Europe, and many other regions outside of China.